Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review
- PMID: 31576593
- DOI: 10.1111/pde.14005
Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review
Abstract
Cutaneous polyarteritis nodosa (CPAN) is a rare necrotizing vasculitis affecting small- to medium-sized arteries. Reported treatments include oral corticosteroids alone or in combination with non-steroidal antiinflammatory drugs, intravenous immunoglobulins, cyclophosphamide, azathioprine, colchicine, or dapsone. However, some patients with CPAN do not respond to such treatments and continue to experience exacerbations over prolonged periods. This series provides support for the use of TNF-α inhibitors in the treatment of recalcitrant CPAN in pediatric patients.
Keywords: TNF-alpha Inhibitor; cutaneous polyarteritis nodosa; vasculitis.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.Intern Med. 2017;56(11):1435-1438. doi: 10.2169/internalmedicine.56.8235. Epub 2017 Jun 1. Intern Med. 2017. PMID: 28566612 Free PMC article.
-
[Cutaneous periarteritis nodosa resistant to combined corticosteroids and immunosuppressive agents. Efficacy of treatment with intravenous immunoglobulins].Ann Dermatol Venereol. 1995;122(11-12):769-72. Ann Dermatol Venereol. 1995. PMID: 8729821 French.
-
Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept.Mod Rheumatol. 2014 Jul;24(4):688-9. doi: 10.3109/14397595.2013.874737. Mod Rheumatol. 2014. PMID: 24981320
-
Infliximab for the treatment of refractory polyarteritis nodosa.Clin Rheumatol. 2019 Oct;38(10):2825-2833. doi: 10.1007/s10067-019-04474-9. Epub 2019 Apr 10. Clin Rheumatol. 2019. PMID: 30972576 Review.
-
Therapeutic options for cutaneous polyarteritis nodosa: a systematic review.Rheumatology (Oxford). 2021 Sep 1;60(9):4039-4047. doi: 10.1093/rheumatology/keab402. Rheumatology (Oxford). 2021. PMID: 33944902
Cited by
-
Methotrexate-Induced Leukocytoclastic Vasculitis.Cureus. 2021 Jul 20;13(7):e16519. doi: 10.7759/cureus.16519. eCollection 2021 Jul. Cureus. 2021. PMID: 34430130 Free PMC article.
-
Localized Forms of Vasculitis.Curr Rheumatol Rep. 2021 Jul 1;23(7):49. doi: 10.1007/s11926-021-01012-y. Curr Rheumatol Rep. 2021. PMID: 34196889 Free PMC article. Review.
References
REFERENCES
-
- Mocan H, Mocan MC, Peru H, Ozoran Y. Cutaneous polyarteritis nodosa in a child and a review of the literature. Acta Paediatr Oslo Nor 1992. 1998;87(3):351-353.
-
- Fink CW. The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa. J Rheumatol Suppl. 1991;29:14-20.
-
- Schaffer JV, Davidson DM, McNiff JM, Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol. 2001;44(2):198-206.
-
- Kumar L, Thapa BR, Sarkar B, Walia BN. Benign cutaneous polyarteritis nodosa in children below 10 years of age-a clinical experience. Ann Rheum Dis. 1995;54(2):134-136.
-
- Sheth AP, Olson JC, Esterly NB. Cutaneous polyarteritis nodosa of childhood. J Am Acad Dermatol. 1994;31(4):561-566.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources